We are live on ! Find out more
ECTE

ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE

Delisted

ECTE was delisted on the 11th of July, 2016.

Back to rankings

2 hedge funds and large institutions have $1K invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

50% less capital invested

Capital invested by funds: $2K → $1K (-$1K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
1
Edge Wealth Management
New York
$1K – – –

ECTE Hedge Fund Activity: Q1 2017 in Review

2 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q1 2017, worth a combined $1K — down 50% from $2K a quarter earlier.

Fund positioning in ECTE was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $1K of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q1 2017, down 50% quarter-over-quarter.
  • 0 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q1 2017 and 0 closed out.

Based on aggregated 13F filings for Q1 2017.